查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1633883

全球过敏药物市场分析与预测（至 2033 年）：类型、产品、服务、技术、应用、最终用户、形式、阶段

Allergy Therapeutics Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 380 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球过敏药物市场规模预计将从 2023 年的 217 亿美元扩大到 2033 年的 438 亿美元，复合年增长率为 7.3%。

过敏药物市场包括用于预防或减轻过敏反应的药物的开发、生产和分销。该市场包括免疫疗法、抗组织胺、皮质类固醇和生物製剂，用于治疗从花粉热到严重过敏反应等多种疾病。过敏症盛行率的上升、生物技术的进步以及对个人化医疗的日益关注正在推动市场的发展，为市场提供了巨大的成长潜力和创新机会。

随着全球对过敏性疾病的认识不断提高以及过敏性疾病的盛行率不断上升，过敏药物市场正在稳步扩张。皮下免疫疗法（SCIT）因其在长期过敏管理中被证实的有效性而引领市场。舌下免疫疗法（SLIT）因其非侵入性及患者依从性而受到关注，成为表现第二好的细分领域。从地区来看，北美占据市场主导地位，这得益于先进的医疗基础设施和过敏性疾病的高发病率。欧洲凭藉其优惠的报销政策以及对过敏治疗研发的高度重视，成为仅次于北美的第二大过敏治疗市场。在亚太地区，人口快速成长和医疗保健投资不断增加正在创造有利可图的成长机会，其中中国和印度是主要贡献者。这些趋势强调了创新和策略联盟对于获得市场占有率和满足全球过敏症患者不断变化的需求的关键性。动态的市场格局要求不断适应不断变化的监管环境和消费者偏好。

预计2023年的市场规模为3.2亿剂，需求旺盛。舌下免疫疗法占最大的市场占有率，为 45%，其次是皮下免疫疗法，为 30%，其他疗法为 25%。这种分布是由于全球范围内人们对非侵入性治疗的偏好日益增加以及过敏性疾病的盛行率不断上升所致。该领域的主要公司包括 ALK-Abello、Stallergenes Greer 和 Allergy Therapeutics plc，它们都在利用其创新的产品线来保持竞争优势。

策略伙伴关係和生物製剂的进步正在塑造竞争格​​局。监管影响，尤其是来自 FDA 和 EMA 的监管影响，对于确定市场进入和合规性至关重要。由于研发投入的增加和对过敏管理认识的不断提高，预计到 2033 年市场将以 10% 的复合年增长率增长。未来前景光明，个人化医疗和数位健康解决方案领域充满商机。然而，课题依然存在，包括监管障碍和已开发地区的市场饱和。人工智慧在患者监测和个人化治疗中的融合预计将推动市场成长。

这个市场存在很大的地区差异。北美因过敏症盛行率高和医疗基础设施先进而具有优势。美国凭藉强劲的研发活动处于领先地位。该地区因人们对创新疗法的认识而不断提高和可用性不断提高而受益，从而增强了其市场领导地位。

欧洲的成长由德国和英国引领，其次是北美。这些国家强调先进的治疗和以病人为中心的治疗方法。欧洲市场受到强有力的监管框架和大量生物技术投资的支持，促进了过敏治疗的快速发展。

由于过敏盛行率上升和医疗保健服务改善，亚太地区正在经历显着增长。中国和日本是领先的国家，它们在研发方面投入大量资金，以满足日益增多的患者的需求。增强诊断能力和治疗选择的努力正在推动该地区的市场扩张。

拉丁美洲和中东及非洲正逐渐获得关注。医疗保健支出的增加和宣传活动的发展促进了市场的成长。巴西和南非是突出的贡献者，致力于加强卫生基础设施和改善过敏治疗的机会。

目录

第 1 章 过敏治疗药物市场概论

  • 研究目标
  • 过敏治疗市场的定义与范围
  • 报告限制
  • 调查年份与货币
  • 研究方法

第 2 章执行摘要

第 3 章 关键市场考量

第 4 章 过敏治疗药物市场展望

  • 过敏治疗市场的细分
  • 市场动态
  • 波特五力分析
  • PESTLE 分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章 过敏治疗药物市场策略

  • 母公司市场分析
  • 供需分析
  • 消费者购买意向
  • 个案研究分析
  • 价格分析
  • 监理状态
  • 供应链分析
  • 竞争产品分析
  • 近期发展

第六章 过敏治疗药物市场规模

  • 过敏治疗药物的市场规模（以价值计算）
  • 过敏治疗药物的市场规模（以数量计算）
第 7 章 过敏治疗药物市场（按类型）
    市场概况
  • 抗组织胺药
  • 皮质类固醇
  • 减充血剂
  • 肥大细胞稳定剂
  • 白三烯抑制剂
  • 免疫疗法
  • 生物製剂
  • 其他
第 8 章 过敏治疗药物市场（依产品）
    市场概况
  • 平板电脑
  • 吸入剂
  • 鼻腔喷剂
  • 眼药水
  • 护肤霜
  • 注入
  • 舌下免疫治疗
  • 其他

第 9 章 过敏药物市场（依服务）

    市场概况
  • 过敏测试
  • 咨询服务
  • 免疫疗法服务
  • 药局服务
  • 其他

第 10 章 过敏药物市场（依技术划分）

    市场概况
  • 生物技术 奈米科技 基因组学
  • 其他
第 11 章 过敏治疗药物市场（依应用）
    市场概况
  • 鼻炎
  • 气喘
  • 异位性皮肤炎
  • 荨麻疹
  • 过敏反应
  • 其他
第 12 章 过敏治疗药物市场（依最终使用者）
    市场概况
  • 医院
  • 诊所
  • 药局
  • 家庭医疗环境
  • 研究机构
  • 其他
第十三章 过敏药物市场（依形式）
    市场概况
  • 基于处方
  • 非处方药
  • 其他

第 14 章 过敏治疗市场（依阶段）

    市场概况
  • 临床前试验 第一阶段 第二阶段 第三阶段
  • 已核准
  • 其他
第 15 章 过敏治疗药物市场（按地区）
  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非
    • 其他中东和非洲地区

第 16 章 竞争格局

  • 概述
  • 市占率分析
  • 主要公司的定位
  • 衝突领导地图
  • 供应商基准测试
  • 对标发展策略

第 17 章 公司简介

  • ALK-Abello
  • Stallergenes Greer
  • Circassia Pharmaceuticals
  • DBV Technologies
  • Allergy Therapeutics
  • HAL Allergy Group
  • Aimmune Therapeutics
  • Leti Pharma
  • Boehringer Ingelheim Vetmedica
  • Aravax
  • Inmunotek
  • AnaptysBio
  • Anergis
  • Adamis Pharmaceuticals
  • Intrommune Therapeutics
  • Alladapt Immunotherapeutics
  • Cambridge Allergy
  • Allovate Therapeutics
  • ASIT biotech
  • Allergy Amulet
简介目录
Product Code: GIS25754

The allergy therapeutics market is anticipated to expand from $21.7 billion in 2023 to $43.8 billion by 2033, reflecting a CAGR of 7.3%.

The Allergy Therapeutics Market encompasses the development, production, and distribution of treatments aimed at preventing or alleviating allergic reactions. This market includes immunotherapy, antihistamines, corticosteroids, and biologics, addressing conditions ranging from hay fever to severe anaphylaxis. It is driven by increasing prevalence of allergies, advancements in biotechnology, and a growing focus on personalized medicine, offering significant growth potential and innovation opportunities.

The Allergy Therapeutics Market is witnessing robust expansion, driven by heightened awareness and prevalence of allergic conditions globally. Subcutaneous Immunotherapy (SCIT) leads the market, attributed to its efficacy in long-term allergy management. Sublingual Immunotherapy (SLIT) emerges as the second-highest performing sub-segment, gaining traction due to its non-invasive nature and patient compliance. Regionally, North America dominates the market, propelled by advanced healthcare infrastructure and high allergic disease incidence. Europe follows closely, benefiting from favorable reimbursement policies and a strong focus on research and development in allergy treatments. In the Asia-Pacific region, burgeoning populations and rising healthcare investments create lucrative growth opportunities, with China and India poised as key contributors. These trends underscore the critical importance of innovation and strategic alliances in capturing market share and addressing the evolving needs of allergy sufferers worldwide. The market's dynamic landscape demands continuous adaptation to regulatory changes and consumer preferences.

In 2023, the market was characterized by a robust demand, with the market volume estimated at 320 million doses. The sublingual immunotherapy segment commands the largest market share at 45%, followed by subcutaneous immunotherapy at 30%, and other treatment modalities at 25%. This distribution is driven by the increasing preference for non-invasive treatments and the growing prevalence of allergic diseases globally. Key players in this domain include ALK-Abello, Stallergenes Greer, and Allergy Therapeutics plc, each leveraging innovative product pipelines to maintain competitive advantage.

The competitive landscape is shaped by strategic partnerships and advancements in biologics. Regulatory influences, particularly from the FDA and EMA, are pivotal in determining market entry and compliance. The future outlook remains promising, with opportunities in personalized medicine and digital health solutions. However, challenges such as regulatory hurdles and market saturation in developed regions persist. The integration of AI in patient monitoring and treatment personalization is anticipated to enhance market growth.

The market exhibits significant regional variations. North America dominates due to high prevalence of allergies and advanced healthcare infrastructure. The United States leads, driven by robust research and development activities. This region benefits from increased awareness and availability of innovative treatments, reinforcing its market leadership.

Europe follows closely, with countries like Germany and the United Kingdom spearheading growth. These nations emphasize cutting-edge therapies and patient-centered approaches. The European market is bolstered by strong regulatory frameworks and substantial investments in biotechnology, facilitating rapid advancements in allergy therapeutics.

The Asia Pacific region is experiencing impressive growth, propelled by rising allergy incidences and improved healthcare access. China and Japan are key players, investing in research and development to cater to their growing patient base. Efforts to enhance diagnostic capabilities and treatment options are driving market expansion in this region.

Latin America and the Middle East & Africa regions are gradually gaining traction. Increased healthcare spending and awareness initiatives are contributing to market growth. Brazil and South Africa are notable contributors, focusing on enhancing healthcare infrastructure and accessibility to allergy treatments.

Key Companies

ALK- Abello, Stallergenes Greer, Circassia Pharmaceuticals, DBV Technologies, Allergy Therapeutics, HAL Allergy Group, Aimmune Therapeutics, Leti Pharma, Boehringer Ingelheim Vetmedica, Aravax, Inmunotek, Anaptys Bio, Anergis, Adamis Pharmaceuticals, Intrommune Therapeutics, Alladapt Immunotherapeutics, Cambridge Allergy, Allovate Therapeutics, ASIT biotech, Allergy Amulet

Sources

World Health Organization, U.S. Food and Drug Administration, European Medicines Agency, National Institutes of Health, Centers for Disease Control and Prevention, American Academy of Allergy, Asthma & Immunology, World Allergy Organization, European Academy of Allergy and Clinical Immunology, Global Initiative for Asthma, National Institute of Allergy and Infectious Diseases, Asthma and Allergy Foundation of America, Allergy and Asthma Network, International Food Allergy & Anaphylaxis Alliance, British Society for Allergy & Clinical Immunology, Australasian Society of Clinical Immunology and Allergy, International Primary Care Respiratory Group, International Conference on Allergy and Clinical Immunology, European Respiratory Society Annual Congress, American Thoracic Society International Conference, World Congress of Asthma

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Allergy Therapeutics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Allergy Therapeutics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Mode
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Mode
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Allergy Therapeutics Market Outlook

  • 4.1 Allergy Therapeutics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Allergy Therapeutics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Allergy Therapeutics Market Size

  • 6.1 Allergy Therapeutics Market Size, by Value
  • 6.2 Allergy Therapeutics Market Size, by Volume

7: Allergy Therapeutics Market, by Type

  • 7.1 Market Overview
  • 7.2 Antihistamines
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Corticosteroids
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Decongestants
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Mast Cell Stabilizers
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Leukotriene Inhibitors
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Immunotherapy
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Biologics
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Others
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region

8: Allergy Therapeutics Market, by Product

  • 8.1 Market Overview
  • 8.2 Tablets
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Inhalers
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Nasal Sprays
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Eye Drops
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Skin Creams
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Injectables
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Sublingual Immunotherapy
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Allergy Therapeutics Market, by Services

  • 9.1 Market Overview
  • 9.2 Allergy Testing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consultation Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Immunotherapy Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Pharmacy Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Allergy Therapeutics Market, by Technology

  • 10.1 Market Overview
  • 10.2 Biotechnology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Nanotechnology
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Genomics
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Allergy Therapeutics Market, by Application

  • 11.1 Market Overview
  • 11.2 Rhinitis
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Asthma
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Atopic Dermatitis
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Urticaria
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Anaphylaxis
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Allergy Therapeutics Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Pharmacies
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Homecare Settings
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Research Institutes
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Allergy Therapeutics Market, by Mode

  • 13.1 Market Overview
  • 13.2 Prescription-Based
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Over-the-Counter
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Allergy Therapeutics Market, by Stage

  • 14.1 Market Overview
  • 14.2 Pre-clinical
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Phase I
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Phase II
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Phase III
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Approved
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Allergy Therapeutics Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Services
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by Application
    • 15.2.7 North America Market Size and Forecast, by End User
    • 15.2.8 North America Market Size and Forecast, by Mode
    • 15.2.9 North America Market Size and Forecast, by Stage
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Services
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by Application
      • 15.2.9.6 United States Market Size and Forecast, by End User
      • 15.2.9.7 United States Market Size and Forecast, by Mode
      • 15.2.9.8 United States Market Size and Forecast, by Stage
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Services
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by Application
      • 15.2.10.6 Canada Market Size and Forecast, by End User
      • 15.2.10.7 Canada Market Size and Forecast, by Mode
      • 15.2.10.8 Canada Market Size and Forecast, by Stage
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Services
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by Application
    • 15.3.7 Europe Market Size and Forecast, by End User
    • 15.3.8 Europe Market Size and Forecast, by Mode
    • 15.3.9 Europe Market Size and Forecast, by Stage
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Mode
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Services
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by Application
      • 15.3.10.6 Germany Market Size and Forecast, by End User
      • 15.3.10.7 Germany Market Size and Forecast, by Mode
      • 15.3.10.8 Germany Market Size and Forecast, by Stage
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Services
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by Application
      • 15.3.11.6 France Market Size and Forecast, by End User
      • 15.3.11.7 France Market Size and Forecast, by Mode
      • 15.3.11.8 France Market Size and Forecast, by Stage
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Services
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by Application
      • 15.3.12.6 Spain Market Size and Forecast, by End User
      • 15.3.12.7 Spain Market Size and Forecast, by Mode
      • 15.3.12.8 Spain Market Size and Forecast, by Stage
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Services
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by Application
      • 15.3.13.6 Italy Market Size and Forecast, by End User
      • 15.3.13.7 Italy Market Size and Forecast, by Mode
      • 15.3.13.8 Italy Market Size and Forecast, by Stage
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Services
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by Application
      • 15.3.14.6 Netherlands Market Size and Forecast, by End User
      • 15.3.14.7 Netherlands Market Size and Forecast, by Mode
      • 15.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Services
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by Application
      • 15.3.15.6 Sweden Market Size and Forecast, by End User
      • 15.3.15.7 Sweden Market Size and Forecast, by Mode
      • 15.3.15.8 Sweden Market Size and Forecast, by Stage
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Services
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by Application
      • 15.3.16.6 Switzerland Market Size and Forecast, by End User
      • 15.3.16.7 Switzerland Market Size and Forecast, by Mode
      • 15.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Services
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by Application
      • 15.3.17.6 Denmark Market Size and Forecast, by End User
      • 15.3.17.7 Denmark Market Size and Forecast, by Mode
      • 15.3.17.8 Denmark Market Size and Forecast, by Stage
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Services
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by Application
      • 15.3.18.6 Finland Market Size and Forecast, by End User
      • 15.3.18.7 Finland Market Size and Forecast, by Mode
      • 15.3.18.8 Finland Market Size and Forecast, by Stage
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Services
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by Application
      • 15.3.19.6 Russia Market Size and Forecast, by End User
      • 15.3.19.7 Russia Market Size and Forecast, by Mode
      • 15.3.19.8 Russia Market Size and Forecast, by Stage
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Mode
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Mode
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Services
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by Application
      • 15.4.9.6 China Market Size and Forecast, by End User
      • 15.4.9.7 China Market Size and Forecast, by Mode
      • 15.4.9.8 China Market Size and Forecast, by Stage
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Services
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by Application
      • 15.4.10.6 India Market Size and Forecast, by End User
      • 15.4.10.7 India Market Size and Forecast, by Mode
      • 15.4.10.8 India Market Size and Forecast, by Stage
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Services
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by Application
      • 15.4.11.6 Japan Market Size and Forecast, by End User
      • 15.4.11.7 Japan Market Size and Forecast, by Mode
      • 15.4.11.8 Japan Market Size and Forecast, by Stage
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Services
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by Application
      • 15.4.12.6 South Korea Market Size and Forecast, by End User
      • 15.4.12.7 South Korea Market Size and Forecast, by Mode
      • 15.4.12.8 South Korea Market Size and Forecast, by Stage
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Services
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by Application
      • 15.4.13.6 Australia Market Size and Forecast, by End User
      • 15.4.13.7 Australia Market Size and Forecast, by Mode
      • 15.4.13.8 Australia Market Size and Forecast, by Stage
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Services
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by Application
      • 15.4.14.6 Singapore Market Size and Forecast, by End User
      • 15.4.14.7 Singapore Market Size and Forecast, by Mode
      • 15.4.14.8 Singapore Market Size and Forecast, by Stage
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Services
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by Application
      • 15.4.15.6 Indonesia Market Size and Forecast, by End User
      • 15.4.15.7 Indonesia Market Size and Forecast, by Mode
      • 15.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Services
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by Application
      • 15.4.16.6 Taiwan Market Size and Forecast, by End User
      • 15.4.16.7 Taiwan Market Size and Forecast, by Mode
      • 15.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Services
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by Application
      • 15.4.17.6 Malaysia Market Size and Forecast, by End User
      • 15.4.17.7 Malaysia Market Size and Forecast, by Mode
      • 15.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Services
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by Application
    • 15.5.7 Latin America Market Size and Forecast, by End User
    • 15.5.8 Latin America Market Size and Forecast, by Mode
    • 15.5.9 Latin America Market Size and Forecast, by Stage
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Services
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by Application
      • 15.5.9.6 Brazil Market Size and Forecast, by End User
      • 15.5.9.7 Brazil Market Size and Forecast, by Mode
      • 15.5.9.8 Brazil Market Size and Forecast, by Stage
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Services
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by Application
      • 15.5.10.6 Mexico Market Size and Forecast, by End User
      • 15.5.10.7 Mexico Market Size and Forecast, by Mode
      • 15.5.10.8 Mexico Market Size and Forecast, by Stage
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Services
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by Application
      • 15.5.11.6 Argentina Market Size and Forecast, by End User
      • 15.5.11.7 Argentina Market Size and Forecast, by Mode
      • 15.5.11.8 Argentina Market Size and Forecast, by Stage
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Mode
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Mode
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Mode
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Services
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by Application
      • 15.6.10.6 UAE Market Size and Forecast, by End User
      • 15.6.10.7 UAE Market Size and Forecast, by Mode
      • 15.6.10.8 UAE Market Size and Forecast, by Stage
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Services
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by Application
      • 15.6.11.6 South Africa Market Size and Forecast, by End User
      • 15.6.11.7 South Africa Market Size and Forecast, by Mode
      • 15.6.11.8 South Africa Market Size and Forecast, by Stage
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Mode
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 ALK-Abello
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 Stallergenes Greer
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 Circassia Pharmaceuticals
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 DBV Technologies
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Allergy Therapeutics
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 HAL Allergy Group
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Aimmune Therapeutics
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Leti Pharma
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Boehringer Ingelheim Vetmedica
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 Aravax
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 Inmunotek
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 AnaptysBio
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Anergis
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Adamis Pharmaceuticals
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Intrommune Therapeutics
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 Alladapt Immunotherapeutics
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Cambridge Allergy
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Allovate Therapeutics
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 ASIT biotech
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Allergy Amulet
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis